Single Oral Dose Study of C13-URA Breath Test in Cancer Patients
Phase 3
- Conditions
- Cancer
- Registration Number
- JPRN-jRCT2080220039
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Patients aged 20 years or older to less than 85 years (at the time of informed consent)
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy, Safety
- Secondary Outcome Measures
Name Time Method